Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QBQKB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
EBC-129
|
|||||
| Synonyms |
EBC 129; EBC-129; EBC129
Click to Show/Hide
|
|||||
| Organization |
Experimental Drug Development Centre, PAREXEL International Corp.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
3.5
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5); Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mc-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
| Combination Type |
vedotin
|
|||||
